Reductions in Antarctic sea ice suggest that emperor penguin colonies will shrink by the end of the century. [ + ]

Admedus (ASX:AHZ) made good progress with the commercialisation of CardioCel during the financial year and hopes to report the results of its subsidiary's HSV-2 trial next quarter. [ + ]

Anatara Lifesciences used BIO 2014 to seek partners for a non-antibiotic diarrhoea treatment, while Life Sciences Queensland has signed an MoU with biotech accelerator Bioindustrial Innovation Canada. [ + ]

AusBiotech has made preliminary comment regarding the establishment of the Entrepreneurs' Infrastructure Programme (EIP), based on questions posed in the EIP Discussion Paper (June 2014). [ + ]

Mesoblast's (ASX:MSB) mesenchymal precursor cells were associated with improved outcomes in end-stage heart failure patients needing to be weaned off LVADs during a recent trial. [ + ]

Universal Biosensors (ASX:UBI) announced a milestone in its tie-up with Siemens Healthcare Diagnostics to develop point-of-care coagulation tests - the first commercial order for PT-INR strips. [ + ]

Bionomics (ASX:BNO) has signed a research collaboration and licensing deal with Merck covering BNC375, a treatment candidate for Alzheimer's and other CNS conditions. [ + ]

Researchers at the University of Michigan (UM) have obtained the first three-dimensional snapshots of the 'assembly line' within microorganisms that naturally produces antibiotics and other drugs. [ + ]

Using photochemical reactions to our advantage requires a deep understanding of the interplay between the electrons and atomic nuclei within a molecular system after that system has been excited by light. [ + ]

By choosing the right pipetting system and eliminating risk and variability from pipetting procedures, users can achieve enhanced accuracy, reduced costs and better overall productivity. [ + ]

The Hunter Medical Research Institute's (HMRI) Pathology Service laboratory has developed DNA sequencing technology that is accelerating screening for the genetic risk of breast and ovarian cancer. [ + ]

Novogen (ASX:NRT) and its CanTx JV have published preclinical data supporting the potential of Trx-1, injected into the peritoneal cavity, as a first-line therapy for ovarian cancer. [ + ]

Mesoblast (ASX:MSB) revealed its MPCs were able to improve glycaemic control during a phase II trial in type 2 diabetes. [ + ]

Recent work on developing targeted treatments for pancreatic cancer is paving the way for new approaches in personalised medicine. [ + ]

Atomo Diagnostics' HIV blood test, AtomoRapid HIV, has been named Best In Show at the Medical Design Excellence Awards. [ + ]